What an amazing night at the ballpark for the Kriya team and our families. It’s great to see our local team the Durham Bulls Baseball Club play and support the growing RTP community!
Kriya Therapeutics, Inc.
Biotechnology Research
Palo Alto, California 14,974 followers
A fully integrated platform company aiming to revolutionize how gene therapies are designed, developed, and manufactured
About us
Kriya Therapeutics, Inc. is a biopharmaceutical company developing gene therapies for diseases affecting millions of people around the world. With operations in Palo Alto, California and Research Triangle Park, North Carolina, Kriya has raised over $450 million to advance a broad pipeline of gene therapies for ophthalmology, neurology, and metabolic diseases.
- Website
-
http://www.kriyatx.com
External link for Kriya Therapeutics, Inc.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Palo Alto, California
- Type
- Privately Held
- Founded
- 2019
- Specialties
- Gene Therapy
Locations
-
Primary
Get directions
Palo Alto, California 94306, US
-
Get directions
Morrisville, NC 27560, US
Employees at Kriya Therapeutics, Inc.
Updates
-
Happy National Intern Day! Kriya is proud to have 9 interns this summer. Their fresh ideas, enthusiasm, and a drive for excellence truly enriches our organization. Thank you Lauren Hullender, Anastasiia Barron, Ankitha Lavu, Lionel Watkins, Sara Wasserman, Faduma Osman, Yoonjung Choi, Kyla Jarrell, Jacob Casey!
-
-
We’ve expanded our leadership team with the appointment of Kriya’s Scientific Co-Founder, J Fraser Wright, PhD, as Chief Gene Therapy Officer to spearhead advancements in our #genetherapy pipeline. Fraser has contributed to numerous gene therapy development programs throughout his career and will continue to be instrumental as we prepare to advance multiple gene therapies into the clinic. Learn more: https://bit.ly/3WeLLLh
-
-
We look forward to participating in the American Diabetes Association's 84th Scientific Sessions this weekend in Orlando. See you there!
-
#News: We’ve expanded our leadership team with the appointment of Katherine E. as Kriya’s Chief Legal Officer to guide legal strategy across corporate affairs, #genetherapy R&D and technology, and manufacturing platforms. Welcome to Team Kriya Kat! Learn more: https://bit.ly/3VItNAl
-
-
Our Co-founder and CEO, Shankar Ramaswamy, M.D., will join Managing Director Whitney Ijem at Canaccord Genuity Group Inc. for a fireside chat to provide insight on developing #genetherapies to address common diseases. Join us for the live event here: https://bit.ly/45qbSBW
-
-
We’re looking forward to presenting at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12th at 10am ET where our Co-founder and CEO, Shankar Ramaswamy, M.D., will share our latest company updates. Hope to see you there!
-
-
Join us today at CTS Retina Clinical Trials at the Summit where our Co-founder and CEO, Shankar Ramaswamy, M.D., will participate in a panel discussion on the latest treatments in #geographicatrophy. We’re proud to sponsor the event: https://www.ctsretina.org/
-
-
The Kriya team was proud to be a part of the Tour de Cure #diabetes fundraising event last month. Thank you to the American Diabetes Association for all you do to increase awareness and improve education in our local community. #TourdeCure2024
-
-
We’re in San Diego this week for the @IAmBiotech BIO International Convention where our President & COO, Curt Herberts, will be on the ground connecting with industry leaders over the next few days. Hope to see you there!
-